A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
Randomized clinical trial of human interleukin-11 in Dengue fever-associated thrombocytopenia
2014
Journal of the College of Physicians and Surgeons
To assess the effectiveness of recombinant human (rh) IL-11 to increase platelets count in patients suffering from Dengue fever (DF). Randomized double blind placebo control study. Farooq Hospital, Lahore, from July to October 2011. Forty hospitalized patients suffering from Dengue fever having platelets count ² 30000 per micro liter were randomly categorized into two groups, rhIL-11 (test) and distilled water (placebo) groups. The efficacy outcomes (as indicated by step up in platelets count
pmid:24613110
fatcat:it622565kzdg7kybv536io23ai